Relationship between kinetic parameters of ultrafast dynamic contrast-enhanced (DCE) MRI and tumor-infiltrating lymphocytes (TILs) in breast cancer

Jpn J Radiol. 2025 Jan;43(1):43-50. doi: 10.1007/s11604-024-01645-w. Epub 2024 Aug 26.

Abstract

Purpose: To evaluate the relationship between kinetic parameters of ultrafast dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) and tumor-infiltrating lymphocytes (TILs) in breast cancer.

Patients and methods: This retrospective study was approved by an institutional review board and included 76 women (median age: 60) with 76 surgically proven breast cancers who underwent DCE MRI including ultrafast sequence. Based on the TILs level, we classified the patients into the low-TILs (< 10%) group and the high-TILs (≥ 10%) group. Maximum slope (MS) and time to enhancement (TTE) derived from ultrafast DCE sequence were correlated in each TILs group. The percentages of six kinetic patterns (fast, medium, and slow from the early phase, washout, plateau, and persistent from the delayed phase) derived from the conventional DCE sequence were also correlated in each TILs group.

Results: Of the 76 breast cancers, 57 were in the low-TILs group and 19 comprised the high-TILs group. The median MS in the high-TILs group (32.4%/sec) was significantly higher than that in the low-TILs group (23.68%/s) (p = 0.037). In a receiver-operating characteristic (ROC) analysis, the area under the curve (AUC) for differentiating between the high- and low-TILs group was 0.661. The TTE in the high-TILs group was significantly shorter than that in the low-TILs group (p = 0.012). In the ROC analysis, the AUC was 0.685. There were no significant differences between the percentages of the six kinetic patterns from the conventional DCE sequence and the TILs level (p = 0.075-0.876).

Conclusion: Compared to the low-TILs group, the high-TILs group had higher MS and shorter TTE.

Keywords: Breast cancer; Magnetic resonance imaging; Prognosis; TILs; Ultrafast.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms* / diagnostic imaging
  • Breast Neoplasms* / immunology
  • Contrast Media*
  • Female
  • Humans
  • Image Enhancement / methods
  • Lymphocytes, Tumor-Infiltrating* / immunology
  • Magnetic Resonance Imaging* / methods
  • Middle Aged
  • Retrospective Studies

Substances

  • Contrast Media